glp-1 news 2025 november Pipeline Update: - Prime Therapeutics GLP-1 Weight-Loss Drug Demonstration Begins

These medications may include adjustments to dosage, form (injection vs

The initial weeks of treatment are often focused on helping your body adjust to the medication

Group at-risk employees to increase engagement Use traditional (assessments and screenings) and advanced (artificial intelligence) methods to offer programs to employees who may benefit from GLP-1 medications

Hear it from women like you Real members on what changed once they stopped fighting their hormones alone

And that, quite frankly, definitely had an effect on maybe some wins that I could have had in my career," Williams recalls

Diabetic ketoacidosis (DKA) risk is a serious concern, particularly for patients using insulin or SGLT2 inhibitors with very-low-carbohydrate diets